Orchid Pharma
Orchid Pharma Performance
Day Range
- Low 564.00
- High 581.00
52 Week Range
- Low 332.75
- High 634.80
- Open Price568.80
- Previous Close564.10
- Volume180878
Start SIP in Orchid Pharma
Start SIPOrchid Pharma Investment Rating
-
Master Rating:
-
Orchid Pharma has an operating revenue of Rs. 751.34 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 8% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 19% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 199 | 183 | 210 | 160 | 165 | 131 | 180 |
| Operating Expenses Qtr Cr | 175 | 161 | 170 | 146 | 147 | 119 | 151 |
| Operating Profit Qtr Cr | 24 | 22 | 40 | 14 | 18 | 12 | 29 |
| Depreciation Qtr Cr | 8 | 8 | 7 | 8 | 18 | 22 | 27 |
| Interest Qtr Cr | 4 | 6 | 7 | 8 | 9 | 8 | 4 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 20 | 11 | 65 | 7 | -3 | -14 | -2 |
Orchid Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹543.45
- 50 Day
- ₹526.64
- 100 Day
- ₹513.33
- 200 Day
- ₹482.34
- 20 Day
- ₹540.15
- 50 Day
- ₹514.10
- 100 Day
- ₹534.59
- 200 Day
- ₹473.30
Orchid Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 579.47 |
| Second Resistance | 588.73 |
| Third Resistance | 596.47 |
| RSI | 62.50 |
| MFI | 51.91 |
| MACD Single Line | 15.63 |
| MACD | 19.23 |
| Support | |
|---|---|
| First Resistance | 562.47 |
| Second Resistance | 554.73 |
| Third Resistance | 545.47 |
Orchid Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 217,471 | 12,241,443 | 56.29 |
| Week | 649,172 | 46,136,672 | 71.07 |
| 1 Month | 197,265 | 14,216,889 | 72.07 |
| 6 Month | 69,106 | 5,823,567 | 84.27 |
Orchid Pharma Result Highlights
Orchid Pharma Synopsis
NSE-Medical-Diversified
Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 665.90 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2023. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.| Market Cap | 2,891 |
| Sales | 751 |
| Shares in Float | 1.42 |
| No of funds | 29 |
| Yield |
| Book Value | 3.18 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | 20 |
| Alpha | 0.16 |
| Beta | 0.85 |
Orchid Pharma
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 72.4% | 72.4% | 89.96% | 89.96% |
| Mutual Funds | 9.76% | 9.78% | 2.45% | 2.45% |
| Insurance Companies | ||||
| Foreign Portfolio Investors | 8.08% | 8.58% | 0.81% | 0.86% |
| Financial Institutions/ Banks | 0.12% | 0.17% | 0.14% | 0.04% |
| Individual Investors | 3.85% | 3.1% | 3.39% | 3.43% |
| Others | 5.79% | 5.97% | 3.25% | 3.26% |
Orchid Pharma Management
| Name | Designation |
|---|---|
| Mr. Ram Gopal Agarwal | Chairman & Non-Exe.Director |
| Mr. Manish Dhanuka | Managing Director |
| Mr. Mridul Dhanuka | Whole Time Director |
| Mrs. Tanu Singla | Independent Director |
| Dr. Dharam Vir | Independent Director |
| Mr. Manoj Kumar Goyal | Independent Director |
| Mr. Mudit Tandon | Independent Director |
Orchid Pharma Forecast
Price Estimates
Orchid Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-04 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | |
| 2023-05-10 | Audited Results | |
| 2023-02-09 | Quarterly Results | |
| 2022-12-01 | Others | Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis. |
Orchid Pharma FAQs
What is Share Price of Orchid Pharma ?
Orchid Pharma share price is ₹570 As on 30 November, 2023 | 05:27
What is the Market Cap of Orchid Pharma ?
The Market Cap of Orchid Pharma is ₹2892 Cr As on 30 November, 2023 | 05:27
What is the P/E ratio of Orchid Pharma ?
The P/E ratio of Orchid Pharma is 30.1 As on 30 November, 2023 | 05:27
What is the PB ratio of Orchid Pharma ?
The PB ratio of Orchid Pharma is 4.2 As on 30 November, 2023 | 05:27